CD30-targeted CAR T-cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD30-targeted CAR T-cell therapy, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma [Phase 1, Phase 2]